06127
- 即時昭衍新藥
- 8.130-0.050 (-0.611%)
- 營業額 / 收益
- 除稅前溢利 / (虧損)
- 股東應佔溢利 / (虧損)
- 每股盈利
- 1,012,077
- 30.274%
- 776,881
- 534,556
- 397,355
- (564,278)
- 41.445%
- (398,939)
- (265,985)
- (200,551)
- 447,799
- 18.484%
- 377,942
- 268,571
- 196,804
- (198,770)
- --
- 131,321
- 37,764
- --
- 116,936
- -73.127%
- 435,148
- 172,631
- 100,033
- (27,428)
- -57.649%
- (64,764)
- (19,538)
- (14,458)
- 90,627
- -75.580%
- 371,120
- 153,735
- 85,976
- (59,180)
- -11.614%
- (66,956)
- (1,111)
- 703
- 57,215
- 13.163%
- 50,560
- 37,389
- 31,616
市場價值指標
- 12.143
- --
- 50.000
- 30.714
- 19.388